EWP
RYTM icon

Elevation Wealth Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

Elevation Wealth Partners’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Hold
1,971
– – 0.07% 128
2026
Q1 		$171K Hold
1,971
– – 0.06% 125
2025
Q4 		$211K Hold
1,971
– – 0.07% 113
2025
Q3 		$199K Hold
1,971
– – 0.07% 114
2025
Q2 		$125K Hold
1,971
– – 0.05% 151
2025
Q1 		$104K Hold
1,971
– – 0.05% 166
2024
Q4 		$110K Hold
1,971
– – 0.05% 157
2024
Q3 		$103K Hold
1,971
– – 0.04% 161
2024
Q2 		$80.9K Hold
1,971
– – 0.04% 175
2024
Q1 		$85.4K Buy
1,971
+1,571
+393% +$68.8K 0.04% 174
2023
Q4 		$9.17K Buy
+400
New +$12.6K 0.01% 339

Other funds holding RYTM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Elevation Wealth Partners's RYTM Position: Q2 2026 in Review

Elevation Wealth Partners held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 1,971 shares worth $219K. The position accounts for 0.07% of the portfolio, ranked #128.

Elevation Wealth Partners first reported a position in RYTM in Q4 2023 and has held it in 11 quarters since. 20 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Elevation Wealth Partners held 1,971 shares of Rhythm Pharmaceuticals worth $219K as of Q2 2026.
  • Elevation Wealth Partners left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
  • Rhythm Pharmaceuticals made up 0.07% of Elevation Wealth Partners's portfolio in Q2 2026, its #128 holding.
  • Elevation Wealth Partners first reported a position in Rhythm Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 20 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.